241 related articles for article (PubMed ID: 29374850)
21. Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cells.
Saeed K; Ojamies P; Pellinen T; Eldfors S; Turkki R; Lundin J; Järvinen P; Nisen H; Taari K; Af Hällström TM; Rannikko A; Mirtti T; Kallioniemi O; Östling P
Int J Cancer; 2019 Mar; 144(6):1356-1366. PubMed ID: 30125350
[TBL] [Abstract][Full Text] [Related]
22. Discovering intratumor heterogeneity: the next frontier for pathologists.
López JI; De Petris G
Pathologica; 2017 Jun; 109(2):110-113. PubMed ID: 28748969
[TBL] [Abstract][Full Text] [Related]
23. Clear cell papillary renal cell carcinoma as part of histologically discordant multifocal renal cell carcinoma: A case report and review of literature.
Shao T; Yousef P; Shipilova I; Saleeb R; Lee JY; Krizova A
Pathol Res Pract; 2016 Mar; 212(3):229-33. PubMed ID: 26857533
[TBL] [Abstract][Full Text] [Related]
24. Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes.
Lawrie CH; Larrea E; Larrinaga G; Goicoechea I; Arestin M; Fernandez-Mercado M; Hes O; Cáceres F; Manterola L; López JI
J Pathol; 2014 Jan; 232(1):32-42. PubMed ID: 24155122
[TBL] [Abstract][Full Text] [Related]
25. Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma.
Johnson TV; Ali S; Abbasi A; Kucuk O; Harris WB; Ogan K; Pattaras J; Nieh PT; Marshall FF; Osunkoya AO; Master VA
J Urol; 2011 Oct; 186(4):1213-7. PubMed ID: 21849188
[TBL] [Abstract][Full Text] [Related]
26. Intratumor Heterogeneity in Breast Cancer.
Beca F; Polyak K
Adv Exp Med Biol; 2016; 882():169-89. PubMed ID: 26987535
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
28. Chromosomes in renal carcinoma with reference to intratumor heterogeneity.
Nordenson I; Ljungberg B; Roos G
Cancer Genet Cytogenet; 1988 May; 32(1):35-41. PubMed ID: 3162706
[TBL] [Abstract][Full Text] [Related]
29. [Non clear cell renal cell carcinoma. 2008 update in renal tumor pathology].
Sibony M; Vieillefond A
Ann Pathol; 2008 Oct; 28(5):381-401. PubMed ID: 19068393
[TBL] [Abstract][Full Text] [Related]
30. GALNT4 predicts clinical outcome in patients with clear cell renal cell carcinoma.
Liu Y; Liu W; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
J Urol; 2014 Nov; 192(5):1534-41. PubMed ID: 24769034
[TBL] [Abstract][Full Text] [Related]
31. Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma.
Massari F; Ciccarese C; Bria E; Porta C; La Russa F; Knuutila S; Artibani W; Porcaro AB; Bimbatti D; Modena A; Sava T; Tortora G; Cheng L; Eccher A; Cima L; Pedron S; Ghimenton C; Martignoni G; Brunelli M
Appl Immunohistochem Mol Morphol; 2017 Jan; 25(1):39-43. PubMed ID: 26509904
[TBL] [Abstract][Full Text] [Related]
32. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
[TBL] [Abstract][Full Text] [Related]
33. Synchronous renal cell carcinoma and clear cell hepatocellular carcinoma mimicking metastatic disease.
Hou TC; Wu CC; Yang CR; Wang J
Pathol Res Pract; 2010 May; 206(5):342-5. PubMed ID: 19608351
[TBL] [Abstract][Full Text] [Related]
34. Renal tumors with clear cells. A review.
López JI
Pathol Res Pract; 2013 Mar; 209(3):137-46. PubMed ID: 23433880
[TBL] [Abstract][Full Text] [Related]
35. Multisite tumor sampling enhances the detection of intratumor heterogeneity at all different temporal stages of tumor evolution.
Erramuzpe A; Cortés JM; López JI
Virchows Arch; 2018 Feb; 472(2):187-194. PubMed ID: 28842744
[TBL] [Abstract][Full Text] [Related]
36. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J
Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803
[TBL] [Abstract][Full Text] [Related]
37. Complexity of the genomic landscape of renal cell carcinoma: Implications for targeted therapy and precision immuno-oncology.
Sanfrancesco JM; Cheng L
Crit Rev Oncol Hematol; 2017 Nov; 119():23-28. PubMed ID: 29065981
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma.
Vermassen T; De Meulenaere A; Van de Walle M; Rottey S
Acta Clin Belg; 2017 Feb; 72(1):12-18. PubMed ID: 27356035
[TBL] [Abstract][Full Text] [Related]
39. Management of non-clear cell renal cell carcinoma: Current approaches.
Tsimafeyeu I
Urol Oncol; 2017 Jan; 35(1):5-13. PubMed ID: 27544302
[TBL] [Abstract][Full Text] [Related]
40. Detection of Intratumor Heterogeneity in Modern Pathology: A Multisite Tumor Sampling Perspective.
Cortés JM; de Petris G; López JI
Front Med (Lausanne); 2017; 4():25. PubMed ID: 28321395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
